Ensign Peak Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$473K	Hold	4,486	–	–	﹤0.01%	978
2025 Q4	$392K	Sell	4,486 -6,500	-59%	-$532K	﹤0.01%	1018
2025 Q3	$730K	Sell	10,986 -12,150	-53%	-$691K	﹤0.01%	1201
2025 Q2	$1.28M	Sell	23,136 -3,900	-14%	-$187K	﹤0.01%	1106
2025 Q1	$1.31M	Hold	27,036	–	–	﹤0.01%	1106
2024 Q4	$1.04M	Hold	27,036	–	–	﹤0.01%	1296
2024 Q3	$1.22M	Hold	27,036	–	–	﹤0.01%	1212
2024 Q2	$937K	Hold	27,036	–	–	﹤0.01%	1325
2024 Q1	$782K	Sell	27,036 -1,364	-5%	-$37.1K	﹤0.01%	1474
2023 Q4	$651K	Hold	28,400	–	–	﹤0.01%	1595
2023 Q3	$474K	Buy	28,400 +12,100	+74%	+$235K	﹤0.01%	1607
2023 Q2	$450K	Buy	+16,300	New	+$408K	﹤0.01%	1654
2022 Q4	–	Sell	-12,270	Closed	-$103K	–	2117
2022 Q3	$103K	Buy	12,270 +1,590	+15%	+$15K	﹤0.01%	2088
2022 Q2	$84K	Hold	10,680	–	–	﹤0.01%	1995
2022 Q1	$253K	Hold	10,680	–	–	﹤0.01%	1812
2021 Q4	$365K	Buy	+10,680	New	+$338K	﹤0.01%	1743
2021 Q3	–	Sell	-33,230	Closed	-$1.49M	–	1873
2021 Q2	$1.49M	Hold	33,230	–	–	﹤0.01%	1276
2021 Q1	$861K	Hold	33,230	–	–	﹤0.01%	1471
2020 Q4	$670K	Sell	33,230 -4,222	-11%	-$90.9K	﹤0.01%	1534
2020 Q3	$732K	Buy	+37,452	New	+$703K	﹤0.01%	1426